Acute Respiratory Distress Network (ARDSNet) Studies 07, 08, 09, 11, and 12 Early Versus Delayed Enteral Feeding to Treat People with Acute Lung Injury or Acute Respiratory Distress Syndrome (EDEN)
Note that you will be prompted to log in or register an account
Accession Number
HLB01171414a
Study Type
Clinical Trial
Collection Type
Open BioLINCC Study
See bottom of this webpage for request information
Study Period
12/2007 – 5/2011
NHLBI Division
DLD
Dataset(s) Last Updated
August 5, 2024
Study Website
http://www.ardsnet.org/
Clinical Trial URLs
https://clinicaltrials.gov/show/NCT00883948
Primary Publication URLs
http://www.ncbi.nlm.nih.gov/pubmed/22307571
Consent
Commercial Use Data Restrictions No
Data Restrictions Based On Area Of Research No
Commercial Use Specimen Restrictions Yes
Non-Genetic Use Specimen Restrictions Based On Area Of Use Yes
Genetic Use Of Specimens Allowed? Yes, For Some Specimens
Genetic Use Area Of Research Restrictions Yes
Specific Consent Restrictions
Non-genetic use of biospecimens is restricted to research involving lung injury, other lung disease or critical care diseases. Use of biospecimens in genetic research is tiered to (1) research in acute respiratory distress syndrome (ARDS), or (2) research in other medical conditions. Biospecimens cannot be used directly to produce commercial products.
Objectives
To determine if initial lower-volume trophic enteral feeding would increase ventilator-free days (VFDs) and decrease gastrointestinal intolerances compared with initial full enteral feeding.
Background
Mechanically ventilated patients cannot eat normally and if not fed for long periods become malnourished. Because malnutrition is associated with poor outcomes in critically ill patients, artificial nutrition is often provided, especially in those with acute lung injury (ALI) and with expected longer duration of mechanical ventilation. When feasible, enteral nutrition targeting full caloric needs has been advocated over parenteral nutrition. However, feeding intolerance and common care practices often serve as practical barriers to reaching recommended goals.
Although confounded by indication and severity of illness, several observational studies have shown improved clinical outcomes, including fewer infections, shorter duration of mechanical ventilation, and lower mortality for patients receiving a higher percentage of calculated caloric needs. Nonetheless, the best timing, formulation, and amount of enteral nutrition remain unknown.
Participants
Patients within 48 hours of ALI onset who had received mechanical ventilation for less than 72 hours and whose physicians intended to administer enteral nutrition were eligible. ALI was defined by a ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FIO2) of less than 300 (adjusted if altitude exceeded 1000 m) with bilateral pulmonary infiltrates consistent with edema on chest radiograph without clinical evidence of left atrial hypertension.
Design
Participants were randomized, stratified by site and presence of shock at enrollment, to receive either trophic or full enteral feeding for the first 6 days of mechanical ventilation. The initial 272 patients were also simultaneously randomized to a separate trial (the OMEGA study) comparing a nutritional supplement containing omega-3 fatty acids and antioxidants with an isocaloric, isovolemic control in a 2 × 2 factorial design.
The designated feeding strategy was initiated within 6 hours of randomization and continued until death, extubation, or day 6. The care of mechanically ventilated patients still receiving enteral feedings after day 6 was managed according to the full feeding strategy in both groups. In extubated patients who then required reintubation, enteral nutrition was restarted and managed according to the study protocol.
In the full-feeding group, enteral nutrition was initiated at 25 mL/h and advanced to goal rates as quickly as possible. Gastric residual volumes were checked every 6 hours while enteral feeding was increased. Patients randomized to the initial trophic-feeding group had enteral nutrition initiated at 10 mL/h (10-20 kcal/h) for the first 272 patients who also received the omega-3 or control supplement (240 mL volume per day). After the data and safety monitoring board stopped the OMEGA portion of the factorial design, the initial trophic feeding rate was changed to 20 kcal/h to approximate the calories that had been delivered in the OMEGA study. GRVs were checked every 12 hours during trophic feeding. In patients randomized to trophic feeding, enteral nutrition was advanced to full-energy feeding rates following the same protocol used for the full-feeding group if they were still receiving mechanical ventilation at 144 hours.
Conclusions
There was no difference between groups with regard to the primary end point, VFDs to day 28. There also were no differences in 60-day mortality, organ failure−free days, ICU-free days, or the incidence of infection between groups. Similarly, there were no differences between groups in VFDs or survival when analyzed by body mass index category or when subsets of patients with shock or more severe lung injury (acute respiratory distress syndrome) were examined.
JAMA. 2012 Feb 22;307(8):795-803.
Additional Details
Trophic Feeding: 508
Full Feeding: 492
EDEN full | EDEN trophic | All | ||||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
17-20 | 8 | 1.63 | 12 | 2.36 | 20 | 2.00 |
21-25 | 18 | 3.66 | 20 | 3.94 | 38 | 3.80 |
26-30 | 20 | 4.07 | 35 | 6.89 | 55 | 5.50 |
31-35 | 25 | 5.08 | 26 | 5.12 | 51 | 5.10 |
36-40 | 36 | 7.32 | 32 | 6.30 | 68 | 6.80 |
41-45 | 41 | 8.33 | 47 | 9.25 | 88 | 8.80 |
46-50 | 75 | 15.24 | 51 | 10.04 | 126 | 12.60 |
51-55 | 80 | 16.26 | 68 | 13.39 | 148 | 14.80 |
56-60 | 51 | 10.37 | 62 | 12.20 | 113 | 11.30 |
61-65 | 40 | 8.13 | 44 | 8.66 | 84 | 8.40 |
65-70 | 38 | 7.72 | 37 | 7.28 | 75 | 7.50 |
71-75 | 19 | 3.86 | 25 | 4.92 | 44 | 4.40 |
76-80 | 17 | 3.46 | 30 | 5.91 | 47 | 4.70 |
81-85 | 16 | 3.25 | 12 | 2.36 | 28 | 2.80 |
86-89 | 8 | 1.63 | 7 | 1.38 | 15 | 1.50 |
EDEN full | EDEN trophic | All | ||||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Female | 249 | 50.61 | 241 | 47.44 | 490 | 49.00 |
Male | 243 | 49.39 | 267 | 52.56 | 510 | 51.00 |
EDEN full | EDEN trophic | All | ||||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Not reported | 18 | 3.66 | 27 | 5.31 | 45 | 4.50 |
White | 375 | 76.22 | 387 | 76.18 | 762 | 76.20 |
African American | 80 | 16.26 | 79 | 15.55 | 159 | 15.90 |
Other | 19 | 3.86 | 15 | 2.95 | 34 | 3.40 |
EDEN full | EDEN trophic | All | ||||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Hispanic or Latino | 58 | 11.79 | 60 | 11.81 | 118 | 11.80 |
Not Hispanic or Latino | 434 | 88.21 | 448 | 88.19 | 882 | 88.20 |
Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3 of the BioLINCC handbook describes the components of the review process
Plasma, DNA, Urine, BAL
04/05/2024
| Plasma | DNA | Urine | Bronchial Lavage | Total |
---|---|---|---|---|---|
Day 0 | 4,758 | 892 | 2,981 | 12 | 8,643 |
Day 3 | 3,756 | 0 | 3,153 | 1 | 6,910 |
Day 6 | 2,314 | 0 | 2,014 | 0 | 4,328 |
Day 12 | 1,228 | 0 | 16 | 0 | 1,244 |
04/05/2024
| Plasma | |
---|---|---|
Total number of subjects | Average volume (ml) per subject | |
Day 0 | 990 | 2.46 |
Day 3 | 853 | 3.97 |
Day 6 | 605 | 5.14 |
Day 12 | 277 | 6.03 |
| DNA | ||
---|---|---|---|
Total number of subjects | Average mass (µg) per subject | Average volume (ml) per subject | |
Day 0 | 878 | 677.04 | 0.99 |
| Urine | |
---|---|---|
Total number of subjects | Average volume (ml) per subject | |
Day 0 | 941 | 5.17 |
Day 3 | 804 | 6.44 |
Day 6 | 548 | 5.53 |
Day 12 | 4 | 6.65 |
| Bronchial Lavage | |
---|---|---|
Total number of subjects | Average volume (ml) per subject | |
Day 0 | 4 | 0.85 |
Day 3 | 1 | 0.15 |
Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.
Resources Available
Specimens and Study DatasetsMaterials Available
- Bronchial Lavage
- DNA
- Plasma
- Urine
- More Details
Study Documents
- Data Dictionary (PDF - 7.0 MB)
- Forms EDEN only (PDF - 732.7 KB)
- Forms EDEN-Omega (PDF - 790.4 KB)
- Protocol EDEN only (PDF - 1.6 MB)
- Protocol EDEN-Omega (PDF - 1.2 MB)
Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.